Pediatric Burn Survivors Benefit From Low-Dose Growth Hormone Therapy2/26/04 [Medscape Medical News] Long-term administration of growth hormone in children who survive severe burn injuries significantly improves lean muscle mass and metabolic state, but increasing the dose does not increase the benefit.
The materials presented here were prepared by independent authors under the editorial supervision of Medscape, and do not represent a publication of the Society of Critical Care Medicine. These materials and the related activity are not sanctioned by the Society of Critical Care Medicine or the commercial supporter of the conference, and do not constitute an official part of that conference.
The material presented here does not reflect the views of Society of Critical Care Medicine, Medscape or the companies providing unrestricted educational grants. These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers or continuing education participants should verify all information and data before treating patients or employing any therapies described in this educational activity.
